Summary
To investigate the possibility of detecting carcinomas of the pancreas at an early stage by mass screening of persons without symptoms or by screening the outpatients with gastrointestinal complaints or jaundice, we performed a multicentral study of the mass screening of 10,162 persons at five local areas and of the outpatient screening of 4506 at 17 hospitals for pancreatic cancer in Japan for two years from 1984 to 1985, using serum CA19-9 and elastase-1 determinations or ultrasonography.
Mass screening of 10,162 persons over 40 years old found only four (0.04%) cases of pancreatic cancer, including one case that was curatively treated. According to the screening of 4506 outpatients with gastrointestinal complaints or icterus, 85 (1.9%) patients were found to have pancreatic cancer. Of these 85 patients, 28 could undergo curative treatment. In addition to them, 73 (1.6%) patients with other digestive organ cancer were found. Our results suggest that the mass screening of persons without symptoms is not worthwhile in the early detection of pancreatic cancer, but outpatient screening is useful for detecting curative cancers of the pancreas.
Similar content being viewed by others
References
Hayakawa T, Kondo T, Shibata T, Hamano H, Kitagawa M, Sakai Y, Ono H. Sensitive serum markers for detecting pancreatic cancer. Cancer 1988; 61: 1827–1831.
Stenberg WM, Gelfand R, Anderson KK, Glenn J, Kurtzman SH, Sindelar WF, Toskes PP. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986; 90: 343–349.
Wang T-H, Lin J-T, Chen D-S, Shen J-C, Sung J-L. Noninvasive diagnosis of advancedpancreatic cancer by real-time ultrasonography, carcinoembryonic antigen, and carbohydrate antigen 19-9. Pancreas 1986; 1: 219–223.
Ohyanagi H, Ishida T, Uesaka K, Ishida H, Yamamoto M, Okumura S, Saitoh Y, Yamanaka R, Kobayashi T, Fukuyama K. Immunological and physicochemical properties of new tumor marker for pancreatic cancer, KM01, detected by monoclonal antibody. Jap, J. Gastroenterol. 1985; 82: 1572–1579.
Hisamichi S. Public health and mass screening for gastric cancer. J. Gastroenterol. Mass Survey. 1984; 64: 83–90.
Frebourg T, Bercoff E, Manchon N, Senant J, Basuyau J-P, Breton P, Janvresse A, Brunelle P, Bourreille J. The evaluation of CA19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients. Cancer 1988; 62: 2287–2290.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Homma, T., Tsuchiya, R. The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in japan, using ca19-9 and elastase-1 or ultrasonography. Int J Pancreatol 9, 119–124 (1991). https://doi.org/10.1007/BF02925587
Issue Date:
DOI: https://doi.org/10.1007/BF02925587